| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 72 |
| 1 | SPIRONOLACTONE | 58 |
| 2 | OXALIPLATIN | 46 |
| 3 | LACTULOSE | 43 |
| 4 | BEVACIZUMAB | 41 |
| 5 | OMEPRAZOLE MAGNESIUM | 39 |
| 6 | LAMIVUDINE | 36 |
| 7 | LAMIVUDINE ORAL | 36 |
| 8 | RIFAXIMIN | 35 |
| 9 | ASPIRIN | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AFAMELANOTIDE | 1 | 0.0476 |
| 1 | 4% LIDOCAINE | 1 | 0.0303 |
| 2 | BULEVIRTIDE | 1 | 0.0104 |
| 3 | GABA (GAMMA-AMINOBUTYRIC ACID) | 2 | 0.0093 |
| 4 | DOXERCALCIFEROL | 1 | 0.0060 |
| 5 | NELFINAVIR MESYLATE | 10 | 0.0048 |
| 6 | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0047 |
| 7 | THIOTHIXENE | 1 | 0.0046 |
| 8 | OMEPRAZOLE MAGNESIUM, AMOXICILLIN AND RIFABUTIN | 1 | 0.0046 |
| 9 | RIVASTIGMINE TARTRATE | 2 | 0.0043 |
| # | Drug class | Count |
|---|---|---|
| 0 | Loop Diuretic [EPC] | 92 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 68 |
| 2 | Osmotic Laxative [EPC] | 59 |
| 3 | Aldosterone Antagonist [EPC] | 58 |
| 4 | Proton Pump Inhibitor [EPC] | 56 |
| 5 | Factor Xa Inhibitor [EPC] | 51 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 48 |
| 7 | Platinum-based Drug [EPC] | 47 |
| 8 | Corticosteroid [EPC] | 44 |
| 9 | beta-Adrenergic Blocker [EPC] | 44 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin Receptor Agonist [EPC] | 1 | 0.0030 |
| 1 | Ileal Bile Acid Transporter Inhibitor [EPC] | 1 | 0.0022 |
| 2 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 3 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 31 | 0.0013 |
| 4 | Bile Acid [EPC] | 26 | 0.0011 |
| 5 | Rifamycin Antibacterial [EPC] | 38 | 0.0010 |
| 6 | Provitamin D2 Compound [EPC] | 29 | 0.0010 |
| 7 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 39 | 0.0008 |
| 8 | Interferon gamma [EPC] | 1 | 0.0007 |
| 9 | Vitamin K [EPC] | 5 | 0.0006 |